Skip to main content
Clinical Trials/CTRI/2018/04/013359
CTRI/2018/04/013359
Completed
未知

A Study Of Intravenous Dexmedetomidine On Characteristics OfHyperbaric Bupivacaine In Subarachnoid Block For Lower LimbSurgeries

BLK Superspeciality Hospital0 sites150 target enrollmentTBD

Overview

Phase
未知
Intervention
Not specified
Conditions
Health Condition 1: null- ASA I and II patints falling under inclusion and exclusion criteria
Sponsor
BLK Superspeciality Hospital
Enrollment
150
Status
Completed
Last Updated
4 years ago

Overview

Brief Summary

No summary available.

Registry
who.int
Start Date
TBD
End Date
March 8, 2018
Last Updated
4 years ago
Study Type
Interventional

Investigators

Sponsor
BLK Superspeciality Hospital

Eligibility Criteria

Inclusion Criteria

  • 1\. ASA I \& II patient
  • 2\. Patient undergoing lower limb surgeries under subarachnoid block

Exclusion Criteria

  • 1\.Patients belonging to ASA grade III, IV and V.
  • 2\.Patients with liver and renal dysfunction.
  • 3\.Patients with cardiac dysrhythmias.
  • 4\.Patients using ARBs, calcium channel blockers.
  • 5\.Patients with body weight \> 100 kg or height \<150 cms.
  • 6\.Patients with contraindications for spinal anesthesia \- past history of spine surgery, infection focus at back, coagulopathy hypersensitivity to local anaesthetics or deep vein thrombosis.
  • 7\.Patients with allergy to the study drugs.
  • 8\.Patients with sedative drugs consumption.
  • 9\.Patients with history of uncontrolled, labile hypertension.
  • 10\.Patients with failure of spinal block and the need for general anesthesia.

Outcomes

Primary Outcomes

Not specified

Similar Trials